Metastatic Hormone Refractory Prostate Cancer Completed Phase 4 Trials for Prednisone (DB00635)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02074137Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate CancerTreatment